Statistics
Publications
160
Citations
8.5K
H-Index
54
Active since
2007
Na Lu is an author at China Pharmaceutical University specializing in oncology, molecular oncology, and medicine.
Publications per year
2007–2024
160
160
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1
Binyan Lin, Xiuming Song, Dawei Yang et al. · Gene · 2018 · 396 citations
Medicine, Oncology, Pharmacology +8
Yun Ling, Yong Yang, Na Lu et al. · Biochemical and Biophysical Research Communications · 2007 · 251 citations
Ling Wang, Yun Ling, Yan Chen et al. · Cancer Letters · 2010 · 200 citations
Medicine, Oncology, Pharmacology +8
Isolation and characterization of cancer stem like cells in human glioblastoma cell lines
Lei Qiang, Yong Yang, Yanjun Ma et al. · Cancer Letters · 2009 · 198 citations
Medicine, Cell Biology, Oncology +14
1–5 of 160